share_log
Reuters ·  May 1 08:47
Altamira Therapeutics Announces Filing of Provisional Patent Application for Oligophore Nanoparticles With Sirna Targeting P65 Protein in Treatment of Cancer and Inflammation
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment